Design
Review
Authors
Loading...
Fatty acid beta-oxidation inhibition should not yet change heart disease management; leaves open therapeutic potential pending randomized trials.
Key points are not available for this paper at this time.
Lopaschuk et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: